VivoSeq
Other

Breast Reconstruction

2

Pipeline Programs↗

7

Active Trials↗

3

Companies Involved↗

Breast Reconstruction is an early-stage landscape with 2 programs across 3 companies. The most active players are Pfizer, Garnet BioTherapeutics, Inc., GCA (Eurosilicone).

Intelligence

Pipeline Metrics

Competitive Density

28/100

Pipeline Velocity

11/100

Mech. Concentration

100/100

Completion Rate

67/100

Attrition Rate

20/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Pfizer logo

Pfizer

1 program

Phase 1G

Garnet BioTherapeutics, Inc.

0 programs

PreclinicalG

GCA (Eurosilicone)

0 programs

Preclinical

Pipeline

Programs by Phase

Preclinical
No programs
Phase 12

Minoxidil

Pfizer

Hair Mousse

Duke University

Phase 2
No programs
Phase 3
No programs
Approved
No programs

Analysis

Trial Status

30

clinical trials

Completed12 · 40%
Recruiting6 · 20%
Unknown status5 · 17%
Withdrawn3 · 10%
Terminated3 · 10%
Active, not recruiting1 · 3%

Clinical Trials

Trial Activity

30 trials

Goal-directed Fluid Therapy During Deep Inferior Epigastric Perforator (DIEP) Free Flap Breast Reconstruction
Recruiting·AAlgemeen Ziekenhuis Maria Middelares·Phase 4·NCT06080178·82 enrolled
Evaluation of the Clinical Effectiveness and Safety of Acellular Dermal Matrix(SC DERM® Recon) in Breast Reconstruction
Recruiting·DDOF Inc.·N/A·NCT06555692·120 enrolled
Access my Breast Cancer Care - Use of an eHealth App in Navigating the Breast Cancer Trajectory: A Randomized Controlled Trial
Recruiting·UUniversity of British Columbia·Preclinical·NCT07696637·148 enrolled
Assessment of Topical Minoxidil on Intraoperative Flap Perfusion and Cutaneous Flap Viability in Breast Reconstruction
Recruiting·DDuke University·Phase 1·NCT07264790·25 enrolled
A Prospective, Multi-center, Observational, Non Comparative, Post-marketing Surveillance Study to Obtain Clinical Outcome Data on the Nagor PERLE Range of Silicone Breast Implants When Used in Breast Implantation
Recruiting·GGCA (Eurosilicone)·N/A·NCT06013514·60 enrolled
Bioimpedance Measurement of Abdominal Free Flaps During Arterial and Venous Weaning in Breast Reconstruction
Recruiting·CCentre Hospitalier Universitaire, Amiens·Preclinical·NCT05710705·10 enrolled
Post-Approval Study of the Safety and Effectiveness of the Mentor Smooth Larger Size MemoryGel Ultra High Profile (UHP-L) Breast Implants in Subjects Who Are Undergoing Primary Breast Reconstruction or Revision Reconstruction
Active, not recruiting·MMentor Worldwide, LLC·Preclinical·NCT02724371·400 enrolled
Pain Management Following TRAM Flap for Breast Reconstruction
Completed·MM.D. Anderson Cancer Center·N/A·NCT00500565·61 enrolled
The Use of Pecs Blocks in Combination With Exparel in Breast Reconstruction Surgery
Completed·NNorthwestern University·Phase 3·NCT05171179·60 enrolled
TIVA Admnistration and Autologous Fat Transfer in Breast Reconstruction
Completed·NNational and Kapodistrian University of Athens·N/A·NCT04077827·46 enrolled
Postoperative Antibiotic Requirements Following Immediate Breast Reconstruction
Completed·SStony Brook University·Phase 4·NCT01244698·132 enrolled
Botulinum Toxin A (Botox) in Tissue Expander Breast Reconstruction
Completed·MMayo Clinic·Phase 3·NCT01591746·131 enrolled
Comparing Local Anesthetics for TAP Block During Abdominally-based Free Flap for Breast Reconstruction
Completed·VVanderbilt University Medical Center·Phase 4·NCT03700970·60 enrolled
Deep Inferior Epigastric Artery Flap for Breast Reconstruction
Completed·—·N/A·NCT05088239·108 enrolled
Pain Study Using Intermittent Bupivacain Injections After Breast Reconstruction With DIEP Flap
Completed·UUllevaal University Hospital·Phase 2·NCT00804674·47 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)